CAPTRUST Financial Advisors
MGNX icon

CAPTRUST Financial Advisors’s MacroGenics MGNX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,536
Closed -$159K – 2449
2023
Q4 		$159K Buy
16,536
+934
+6% +$6.46K ﹤0.01% 2447
2023
Q3 		$72.7K Sell
15,602
-514
-3% -$2.56K ﹤0.01% 2454
2023
Q2 		$86.2K Buy
+16,116
New +$99.4K ﹤0.01% 2391
2022
Q3 		– Sell
-472
Closed -$1K – 3238
2022
Q2 		$1K Buy
472
+360
+321% +$1.89K ﹤0.01% 4699
2022
Q1 		$1K Hold
112
– – ﹤0.01% 4714
2021
Q4 		$2K Hold
112
– – ﹤0.01% 4423
2021
Q3 		$2K Sell
112
-34
-23% -$819 ﹤0.01% 4278
2021
Q2 		$4K Hold
146
– – ﹤0.01% 3951
2021
Q1 		$5K Buy
146
+17
+13% +$413 ﹤0.01% 3738
2020
Q4 		$3K Hold
129
– – ﹤0.01% 3006
2020
Q3 		$3K Hold
129
– – ﹤0.01% 2672
2020
Q2 		$4K Buy
+129
New +$2.24K ﹤0.01% 2449

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CAPTRUST Financial Advisors's MGNX Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of MacroGenics (MGNX) in Q1 2024, closing a stake of 16,536 shares — an estimated $159K sold.

CAPTRUST Financial Advisors first reported a position in MGNX in Q2 2020 and held it in 12 quarters. The position peaked at $159K in Q4 2023. 163 funds tracked by Wall St. Rank hold MGNX as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining MacroGenics position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 16,536 MacroGenics shares in Q1 2024, an estimated $159K.
  • CAPTRUST Financial Advisors first reported a position in MacroGenics in Q2 2020 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's MacroGenics position peaked at $159K in Q4 2023.
  • 163 funds tracked by Wall St. Rank held MacroGenics as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.